Commit To Purchase Kymera Therapeutics At $12.50, Earn 13.2% Using Options
Investors considering a purchase of Kymera Therapeutics Inc (Symbol: KYMR) shares, but cautious about paying the going market price of $22.35/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1803777103-b9626d35c9fd4424ae7ecc3b6d58a558.jpg "Accountant Career Path and Qualifications")
:max_bytes(150000):strip_icc():format(jpeg)/AFFLUENT.MILLENNIAL.HERO.GettyImages-868506558_2600-84706e45802340b1865d4b49c285a662.jpg "The Affluent Millennial Investing Survey")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2151279555-f38549a64433496982ff93944b309afb.jpg "5 Transamerica Mutual Funds to Consider")
